Position Title:

Engineering Graduate Intern - Summer 2027

Job Description:

This role requires associates to be in-office 1-2 days per week, fostering collaboration and connectivity, while providing flexibility to support productivity and work-life balance. This approach combines structured office engagement with the autonomy of virtual work, promoting a dynamic and adaptable workplace. Alternate locations may be considered if candidates reside within a commuting distance from an office.

Locations: Chicago, Atlanta, Indianapolis, Mason and Richmond.

Please note that per our policy on hybrid/virtual work, candidates not within a reasonable commuting distance from the posting location(s) will not be considered for employment, unless an accommodation is granted as required by law.

The Graduate Engineering Intern will support engineering teams in the design, development, testing, and validation of computer hardware, embedded systems, software, and integrated technologies for the company’s Digital Platforms and AI Organization (DPAIO). This internship provides hands-on experience working on projects involving hardware and software integration, system performance, automation, and product development while applying engineering principles in a collaborative environment.

During the program our Interns will receive an orientation to the company and engage in challenging projects evolving around the rapidly changing healthcare tech industry. Interns are paired with industry professionals and mentors and will be given opportunities to stretch their skills and enrich their knowledge base to achieve a greater understanding within technology.

How you will make an impact:

Responsible for developing strategies, programs and solutions based on business priorities, consumer insights and industry trends that support digital strategy.

Develop, test, and maintain software tools, scripts, or applications that improve engineering processes.

Participate in system performance analysis, troubleshooting, and root cause investigations.

Assist in the development and execution of test plans and validation procedures.

Collaborate with cross-functional teams including Software Engineering, Systems Engineering, Quality, and Product Development.

Create and maintain technical documentation, user guides, and design documentation.

Present project results and recommendations to engineering leadership.

Create, gather and assess market requirements through competitive intelligence and emerging trends, stakeholder and consumer feedback.

Reimagine how technology works to deliver new capabilities, maintain system efficiency, and reinvest in accelerating transformation.

Leverage AI to transform business processes, automate systems, and deliver the best service and experiences for our stakeholders

Deliver technology capabilities cost efficiently to enable growth of topline revenue for the enterprise.

Minimum Qualifications:

Able to work 40 hours per week for the duration of internship program (May - August 2027)

Currently enrolled in an accredited Masters degree program in Information Technology, Computer Science, Data Analytics, Actuarial Science, Mathematics or a related field of study.

Students must be authorized to work in the U.S. without future visa sponsorship requirements

For the Veteran internship, candidates do not need to be students as military experience and training can be substituted for educational experience.

Preferred Skills, Capabilities and Experiences:

Students will be assigned to a specific group within DPAIO based on skill set and need of the business. Students should have experience and education in:

Critical thinking and analytical skills

Proficiency in technical aspects of computer and software engineering

Advanced knowledge of multiple technologies such as, but not limited to Java React, PySpark, Python, SQL, C++, Software Development & Testing, Software Development & Architecture, Cloud Computing, AI, ML, LLM, AWS Cloud, Snowflake, Azure. Technologies used vary team to team.

Ability to convey the problem and solution pictorially using Powerpoint, Miro or other equivalent technologies.

Advanced user of Excel, PowerPoint, and Word

Proven analytical skills, excellent written and oral communication abilities

For candidates working in person or virtually in the below locations, the salary* range for this specific position is $25.61 to $47.57

Location(s): Chicago, Illinois and Richmond, Virginia

In addition to your salary, Elevance Health offers benefits such as a comprehensive benefits package, incentive and recognition programs, equity stock purchase and 401k contribution (all benefits are subject to eligibility requirements). The salary offered for this specific position is based on a number of legitimate, non-discriminatory factors set by the Company. The Company is fully committed to ensuring equal pay opportunities for equal work regardless of gender, race, or any other category protected by federal, state, and local pay equity laws.

* The salary range is the range Elevance Health in good faith believes is the range of possible compensation for this role at the time of this posting. This range may be modified in the future and actual compensation may vary from posting based on geographic location, work experience, education, and/or skill level. Even within the range, the actual compensation will vary depending on the above factors as well as market/business considerations. No amount is wages or compensation until such amount is earned, vested, and determinable under the terms and conditions of the applicable policies and plans. The amount and availability of any bonus, commission, benefits, or any other form of compensation and benefits that are.

Job Level:

Non-Management Non-Exempt

Job Family:

IFT > IT Intern/Co-Op

Please be advised that Elevance Health only accepts resumes for compensation from agencies that have a signed agreement with Elevance Health. Any unsolicited resumes, including those submitted to hiring managers, are deemed to be the property of Elevance Health.

Who We Are

Elevance Health is a health company dedicated to improving lives and communities – and making healthcare simpler. We are a Fortune 25 company with a longstanding history in the healthcare industry, looking for leaders at all levels of the organization who are passionate about making an impact on our members and the communities we serve.

How We Work

At Elevance Health, we are creating a culture that is designed to advance our strategy but will also lead to personal and professional growth for our associates. Our values and behaviors are the root of our culture. They are how we achieve our strategy, power our business outcomes and drive our shared success - for our consumers, our associates, our communities and our business.

We offer a range of market-competitive total rewards that include merit increases, paid holidays, Paid Time Off, and incentive bonus programs (unless covered by a collective bargaining agreement), medical, dental, vision, short and long term disability benefits, 401(k) +match, stock purchase plan, life insurance, wellness programs and financial education resources, to name a few.

Elevance Health operates in a Hybrid Workforce Strategy. Unless specified as primarily virtual by the hiring manager, associates are required to work at an Elevance Health location at least once per week, and potentially several times per week. Specific requirements and expectations for time onsite will be discussed as part of the hiring process.

The health of our associates and communities is a top priority for Elevance Health. We require all new candidates in certain patient/member-facing roles to become vaccinated against COVID-19 and Influenza. If you are not vaccinated, your offer will be rescinded unless you provide an acceptable explanation. Elevance Health will also follow all relevant federal, state and local laws.

Elevance Health is an Equal Employment Opportunity employer, and all qualified applicants will receive consideration for employment without regard to age, citizenship status, color, creed, disability, ethnicity, genetic information, gender (including gender identity and gender expression), marital status, national origin, race, religion, sex, sexual orientation, veteran status or any other status or condition protected by applicable federal, state, or local laws. Applicants who require accommodation to participate in the job application process should submit the following form: Accessibility Accommodation Request Form and a member of the team will be in contact. Qualified applicants with arrest or conviction records will be considered for employment in accordance with all federal, state, and local laws, including, but not limited to, the Los Angeles County Fair Chance Ordinance and the California Fair Chance Act.

Prospective employees required to be screened under Florida law should review the education and awareness resources at HB531 | Florida Agency for Health Care Administration.

About the company

Elevance Health is one of the largest U.S. health insurers, covering people through employers, individual plans, Medicare and Medicaid. It is the Blue Cross Blue Shield licensee in 14 states, where it sells plans under the Anthem name, and it runs government plans under the Wellpoint name in other markets. Its Carelon division runs the CarelonRx pharmacy benefit manager and sells behavioral health, care management and other services to its own plans and outside clients. Elevance earns most of its revenue from premiums paid by employers, members and government programs, plus fees for Carelon services. The company is headquartered in Indianapolis, Indiana.

Company Size

10,001+

Company Stage

IPO

Headquarters

Indianapolis, Indiana

Founded

1944

Get referred to Elevance Health

See people who can refer or advise you

Simplify's Take

What believers are saying

Equity has room to recover: in July 2026 Elevance raised its outlook to at least $27 adjusted earnings per share.
ACA plans are a growth engine: Elevance had about 1 million marketplace members by June 2026, beating its 900,000 outlook.
Leaders target a rebound: in July 2026 management set a goal of at least 12% earnings growth for 2027.

What critics are saying

Medicaid exits cost jobs: Elevance filed notice in September 2026 to cut 216 Louisiana staff, after 85 in D.C.
Medicaid loses money: Elevance expects a 1.75% operating loss there in 2026 and plans more state exits.
Regulators flagged data shortcuts in February 2026: Elevance sent Medicare diagnosis fixes on USB drives, a $935 million liability.

What makes Elevance Health unique

Elevance owns the Blue brand in 14 states: it is the Anthem Blue Cross licensee from California to New York.
Elevance keeps drug spending in-house: its CarelonRx pharmacy benefit manager handles prescriptions for its own plan members.
Carelon sells care beyond insurance: Carelon Services revenue rose 7.2% to $8.0 billion in the quarter ending June 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision insurance
401(k) + match
Paid holidays
Paid Time Off
Incentive bonus programs
Stock purchase plan
Life insurance
Wellness Programs
Financial education resources
Adoption & Surrogacy Assistance
Dependent-care Flexible Spending Account (DCFSA)
Parental Leave

Company News

Yahoo Finance

Oct 23rd, 2026

Elevance Health shares rise 2.6% to $445 as Q3 revenue hits $51B and guidance is raised

Elevance Health shares rose 2.6% to about $445 after the insurer reported third-quarter 2026 results and raised its full-year outlook. It now expects adjusted earnings per share of at least $29 for 2026, and at least 12% adjusted EPS growth in 2027. Revenue reached $51.43 billion, up from $50.71 billion a year earlier. Net income rose to $1.37 billion from $1.19 billion, and basic EPS climbed to $6.30 from $5.32. Profitability is thinner, though. The trailing 12-month net margin fell to 2.5% from 2.8%. The benefit expense ratio was 90.6%. CarelonRx posted about 10.8% operating gains and a 5.3% margin. Medical membership had fallen to 44.9 million by the second quarter.

Yahoo Finance

Oct 22nd, 2026

Elevance Health raises 2026 outlook as Q3 EPS beats by 48.9% on $50.4B revenue

Elevance Health beat Wall Street expectations in the third quarter of 2026 and raised its full-year outlook. Revenue was flat year on year at $50.44 billion, against analyst estimates of $48.93 billion. Adjusted earnings per share were $6.99, 48.9% above the $4.69 consensus. The insurer raised its full-year adjusted EPS guidance to $29 at the midpoint, up 7.4%. Management credited Medicaid rate increases, cost controls, and growth at its Carelon health services unit. It expects Medicaid margins to begin recovering in 2027 and aims to expand Carelon's business beyond its own health plans. Customers totalled 44.88 million, down from 44.95 million in the previous quarter. Shares trade at $436.75, giving a market value of $94.15 billion.

DistilInfo

Oct 22nd, 2026

Four insurers exit Medicaid as margins turn negative.

Four insurers exit Medicaid as margins turn negative. At least four insurers are leaving Medicaid managed care contracts this year and next, a retreat driven by margins that have turned negative as enrollment falls and the remaining members prove costlier to cover. The Medicaid underwriting margin dropped from nearly 3 percent during the public health emergency to negative 1 percent in 2024, below the industry's 1 to 2 percent target, according to a Robert Wood Johnson Foundation analysis. The exits matter for states, which must move members to new plans mid-contract, and for providers, who lose and gain payer relationships as assignments shift. They also raise a question for state Medicaid agencies: whether current rates can sustain a competitive bidding field. Which insurers are exiting Medicaid managed care. According to published reports compiling state and company disclosures: * Centene is leaving two programs. Its Ohana Health Plan exits Hawaii's QUEST managed care program Dec. 31, and Ambetter leaves the Arkansas Health and Opportunity for Me expansion program the same day, reportedly affecting about 70,000 members. * Healthy Blue, a collaboration between Blue Cross and Blue Shield of Louisiana and Elevance Health, ends its Louisiana Medicaid managed care participation Dec. 31, reportedly affecting about 290,000 members. * Elevance Health's Wellpoint exited the District of Columbia managed care program Aug. 1 and is cutting 85 jobs in Washington during the transition. * Baylor Scott & White Health Plan left the Texas Medicaid managed care market in August and cut 321 jobs as it also prepares to exit the individual marketplace. More departures appear likely. On a July earnings call, Elevance executives said they expected additional Medicaid exits over the next 12 to 18 months without naming the markets. Why Medicaid margins collapsed. The core problem is a mismatch between who left the program and how states set rates. Medicaid enrollment peaked at roughly 94.6 million in mid-2023 during pandemic continuous-eligibility protections. After redeterminations resumed, about 25 million people were disenrolled, more than half for administrative or procedural reasons. Enrollment stood at 73.2 million in June 2026, down 5.1 million, or 6 percent, from a year earlier, based on CMS monthly data compiled by KFF. People who left tended to be healthier, which raised the average acuity of those remaining while state capitation rates lagged behind. Medical loss ratios reflect the squeeze. They averaged 90.9 percent in 2024 and rose to 91.2 percent in an analyzed subgroup of states, with Idaho and Minnesota exceeding 100 percent in 2025 and Colorado and Maryland above 95 percent. What insurers are telling investors. Elevance has maintained a full-year 2026 Medicaid operating margin forecast of about negative 1.75 percent, describing 2026 as the trough year. Reporting second-quarter results in July, the company said rate updates came in stronger than expected while cost pressure concentrated in behavioral health, applied behavior analysis therapy, specialty pharmacy, outpatient surgery and emergency department use. Notably, executives attributed that pressure to higher utilization among continuing members rather than a fresh jump in acuity. Chief Financial Officer Mark Kaye said the company was "not seeing a new stepwise acuity reset." Health Benefits Officer Felicia Norwood said Medicaid remains "a very core part of our portfolio," a signal that selective exits are not a wholesale withdrawal. Elevance's second-quarter net income fell 16.6 percent to $1.4 billion, though it raised full-year guidance to adjusted earnings of at least $27 per share. Policy changes ahead. Further enrollment decline looks likely. A national Medicaid work requirement for the expansion population takes effect in 2027 under the budget reconciliation law, and more frequent redeterminations will add administrative churn. Urban Institute analysis cited by the Robert Wood Johnson Foundation projects that 4.6 million to 5.2 million adults in the expansion population could lose coverage. If departures again skew toward healthier members, the acuity problem compounds rather than resolves. What it means for states and providers. State Medicaid agencies face a narrower bidding field precisely as they absorb federal cuts, which weakens their leverage in rate negotiations. Agencies that hold rates down may find fewer bidders at the next procurement. For providers, each exit means renegotiating with whichever plans absorb the members, and transitions carry documented risks of coverage gaps and care disruption. For insurers remaining in Medicaid managed care, the opportunity is market share in states where competitors have left, assuming rates eventually catch up to the acuity they are now covering.

Yahoo Finance

Oct 21st, 2026

Elevance Health beats forecasts with $1.37B Q3 profit on $51.43B revenue

Elevance Health reported third-quarter earnings of $1.37 billion on Wednesday, beating Wall Street expectations. The Indianapolis-based health insurer posted net income of $6.27 per share. Adjusted earnings were $6.99 per share, against an average analyst estimate of $4.66, according to Zacks Investment Research. Revenue reached $51.43 billion. Adjusted revenue was $50.44 billion, ahead of the $48.49 billion analysts expected. Elevance expects full-year earnings of $29 per share.

Daily Political

Oct 21st, 2026

Elevance Health (NYSE: ELV) raises guidance as revenue climbs 0.7%.

Elevance Health (NYSE: ELV) raises guidance as revenue climbs 0.7%. What happened. Elevance Health, Inc. (NYSE: ELV) reported third-quarter 2026 operating revenue of $50.4 billion and raised full-year 2026 guidance. It raised FY 2026 diluted EPS guidance to at least $22.00, adjusted diluted EPS guidance to at least $29.00 and operating cash flow guidance to at least $6.5 billion. Operating revenue rose 0.7% from a year earlier. Diluted EPS was $6.27 and adjusted diluted EPS was $6.99. Quarterly operating cash flow was $1.3 billion, up $0.1 billion year over year. Carelon operating revenue reached $19.3 billion, and Carelon operating gain rose 17% to $0.9 billion. Health Benefits operating revenue was $43.4 billion, but operating gain fell to $0.4 billion from $0.6 billion. The benefit expense ratio was 90.6%, down 70 basis points from a year earlier. The company said stronger performance in Medicare Advantage and Individual ACA helped. It repurchased 0.8 million shares for $330 million and had about $5.0 billion of board-approved share repurchase authorization left. Key numbers. | Metric | Latest | Change | Source | | 3Q 2026 operating revenue | $50.4 billion | from $50.1 billion, +0.7% | SEC 8-K | | 3Q 2026 diluted EPS | $6.27 | from $5.32, +17.9% | SEC 8-K | | 3Q 2026 adjusted diluted EPS | $6.99 | from $6.03, +15.9% | SEC 8-K | | Carelon 3Q 2026 operating revenue | $19.3 billion | from $18.3 billion, +5% | SEC 8-K | | Benefit expense ratio | 90.6% | from 91.3%, -70 bp | SEC 8-K | | FY 2026 operating cash flow guidance | at least $6.5 billion | / | SEC 8-K | Why it matters. OptimistFi's case is that Elevance turns scale into underwriting earnings only if it keeps medical costs in check and converts earnings into cash. This filing helps that case on cash flow, because the company raised FY 2026 operating cash flow guidance to at least $6.5 billion. It also shows a split in the business, with Carelon improving and Health Benefits weakening. Operating revenue increased by $353 million from the prior-year quarter, but operating gain was unchanged at $1.3 billion. The adjusted operating expense ratio rose 90 basis points to 11.3%, which limits the margin story. The main concern is that Health Benefits operating gain fell to $0.4 billion from $0.6 billion, even with the lower benefit expense ratio. What's next. The conference call was set for today at 8:30 a.m. EDT. The fourth quarter 2026 dividend is payable on December 18, 2026 to shareholders of record at the close of business on December 4, 2026. The replay will be available until the end of the day on November 20, 2026. Investors will look for signs that the higher guidance comes with better margins and steady cash flow. More margin recovery would strengthen the case. Another flat operating-gain quarter would weaken it. From optimistfi perps. Sources. * SEC 8-K earnings release - Third-quarter 2026 earnings release and updated guidance. * Form 8-K - Current report filed October 21, 2026. Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research. The full Elevance Health, Inc. investment case, its status and the next test to watch live on the Elevance Health, Inc. thesis page. Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.

Elevance Health

Engineering Graduate Intern

About the job

About the company

Get referred to Elevance Health

Simplify's Take

What believers are saying

What critics are saying

What makes Elevance Health unique

Benefits

Company News